Anti-PD-1 treatment moderately increased the tumor infiltration of CD45+CD8+ T cells and CD45+CD4+ T cells and decreased the infiltration of CD11b+Gr1+ myeloid cells and CD4+FOXP3+ Treg cells in shControl mice (Figure S5E; Figure S6E-F). Here, PTPRC is linked to neoplasm.